Article: As the promise of diagnostic/therapeutic combinations is increasingly recognized, pharmaceutical companies must determine best practices in terms of co-marketing these combinations.

M2 PRESSWIRE-3 February 2006-Research and Markets: As the promise of diagnostic/therapeutic combinations is increasingly recognized, pharmaceutical companies must determine best practices in terms of co-marketing these combinations(C)1994-2006 M2 COMMUNICATIONS LTD

RDATE:03022006

Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c32219) has announced the addition of Integrating Diagnostics and Therapeutics for Targeted Therapies, Part II: The Importance of Calculating the Return on Investment to their offering

As the promise of diagnostic/therapeutic combinations is increasingly recognized, pharmaceutical companies must ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!